Total Payments
$392.20
2024 Payments
$92.79
Companies
6
Transactions
22
Payment Breakdown by Category
Food & Beverage$392.20 (100.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $392.20 | 22 | 100.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| GlaxoSmithKline, LLC. | $174.54 | 11 | $0 (2024) |
| Takeda Pharmaceuticals U.S.A., Inc. | $92.87 | 5 | $0 (2021) |
| Corium, LLC | $42.84 | 2 | $0 (2024) |
| Ironshore Pharmaceuticals Inc. | $41.30 | 2 | $0 (2023) |
| Biogen, Inc. | $21.95 | 1 | $0 (2021) |
| Kyowa Kirin, Inc. | $18.70 | 1 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $92.79 | 5 | Corium, LLC ($42.84) |
| 2023 | $49.23 | 3 | GlaxoSmithKline, LLC. ($27.49) |
| 2022 | $72.67 | 4 | GlaxoSmithKline, LLC. ($53.11) |
| 2021 | $177.51 | 10 | Takeda Pharmaceuticals U.S.A., Inc. ($92.87) |
All Payment Transactions
22 individual payment records from CMS Open Payments
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/02/2024 | Kyowa Kirin, Inc. | Crysvita (Drug) | Food and Beverage | In-kind items and services | $18.70 | General |
| Category: fibroblast growth factor 23 (FGF23) blocking antibody. | ||||||
| 10/17/2024 | GlaxoSmithKline, LLC. | BEXSERO (Biological), PEDIARIX, ROTARIX | Food and Beverage | In-kind items and services | $14.22 | General |
| Category: VACCINES | ||||||
| 08/15/2024 | Corium, LLC | Azstarys (Drug) | Food and Beverage | In-kind items and services | $21.61 | General |
| Category: CNS Stimulant for ADHD | ||||||
| 07/23/2024 | GlaxoSmithKline, LLC. | BEXSERO (Biological), PEDIARIX, ROTARIX | Food and Beverage | In-kind items and services | $17.03 | General |
| Category: VACCINES | ||||||
| 07/01/2024 | Corium, LLC | Azstarys (Drug) | Food and Beverage | In-kind items and services | $21.23 | General |
| Category: CNS Stimulant for ADHD | ||||||
| 09/05/2023 | GlaxoSmithKline, LLC. | BEXSERO (Biological), PEDIARIX, ROTARIX | Food and Beverage | In-kind items and services | $14.62 | General |
| Category: VACCINES | ||||||
| 05/16/2023 | GlaxoSmithKline, LLC. | BEXSERO (Biological), PEDIARIX | Food and Beverage | In-kind items and services | $12.87 | General |
| Category: VACCINES | ||||||
| 01/31/2023 | Ironshore Pharmaceuticals Inc. | JORNAY PM (Drug) | Food and Beverage | Cash or cash equivalent | $21.74 | General |
| Category: CENTRAL NERVOUS SYSTEM STIMULANT | ||||||
| 12/06/2022 | Ironshore Pharmaceuticals Inc. | JORNAY PM (Drug) | Food and Beverage | In-kind items and services | $19.56 | General |
| Category: Central Nervous Stimulant ADHD | ||||||
| 10/13/2022 | GlaxoSmithKline, LLC. | BEXSERO (Biological), PEDIARIX | Food and Beverage | In-kind items and services | $16.85 | General |
| Category: VACCINES | ||||||
| 07/19/2022 | GlaxoSmithKline, LLC. | BEXSERO (Biological), PEDIARIX | Food and Beverage | In-kind items and services | $17.50 | General |
| Category: VACCINES | ||||||
| 04/12/2022 | GlaxoSmithKline, LLC. | BEXSERO (Biological), PEDIARIX | Food and Beverage | In-kind items and services | $18.76 | General |
| Category: VACCINES | ||||||
| 12/02/2021 | Takeda Pharmaceuticals U.S.A., Inc. | VYVANSE (Drug) | Food and Beverage | In-kind items and services | $19.00 | General |
| Category: NEUROSCIENCE | ||||||
| 10/26/2021 | Takeda Pharmaceuticals U.S.A., Inc. | VYVANSE (Drug) | Food and Beverage | In-kind items and services | $18.46 | General |
| Category: NEUROSCIENCE | ||||||
| 09/30/2021 | Takeda Pharmaceuticals U.S.A., Inc. | VYVANSE (Drug) | Food and Beverage | In-kind items and services | $16.78 | General |
| Category: NEUROSCIENCE | ||||||
| 09/14/2021 | GlaxoSmithKline, LLC. | BEXSERO (Biological), MENVEO, PEDIARIX | Food and Beverage | In-kind items and services | $14.54 | General |
| Category: VACCINES | ||||||
| 09/10/2021 | Takeda Pharmaceuticals U.S.A., Inc. | VYVANSE (Drug) | Food and Beverage | In-kind items and services | $21.28 | General |
| Category: NEUROSCIENCE | ||||||
| 08/03/2021 | GlaxoSmithKline, LLC. | PEDIARIX (Biological), BEXSERO, MENVEO | Food and Beverage | In-kind items and services | $15.78 | General |
| Category: VACCINES | ||||||
| 07/27/2021 | Takeda Pharmaceuticals U.S.A., Inc. | VYVANSE (Drug) | Food and Beverage | In-kind items and services | $17.35 | General |
| Category: NEUROSCIENCE | ||||||
| 07/06/2021 | Biogen, Inc. | SPINRAZA (Biological) | Food and Beverage | In-kind items and services | $21.95 | General |
| Category: NEUROLOGY | ||||||
| 06/08/2021 | GlaxoSmithKline, LLC. | BEXSERO (Biological), MENVEO, PEDIARIX | Food and Beverage | In-kind items and services | $19.29 | General |
| Category: VACCINES | ||||||
| 03/25/2021 | GlaxoSmithKline, LLC. | BEXSERO (Biological), PEDIARIX, MENVEO | Food and Beverage | In-kind items and services | $13.08 | General |
| Category: VACCINES | ||||||
About Brandi Hayhurst, APRN
Brandi Hayhurst, APRN is a Pediatrics healthcare provider based in Summersville, West Virginia. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 09/05/2019. The National Provider Identifier (NPI) number assigned to this provider is 1912556655.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Brandi Hayhurst, APRN has received a total of $392.20 in payments from pharmaceutical and medical device companies, with $92.79 received in 2024. These payments were reported across 22 transactions from 6 companies. The most common payment nature is "Food and Beverage" ($392.20).
Ad
Practice Information
- Specialty Pediatrics
- Location Summersville, WV
- Active Since 09/05/2019
- Last Updated 09/05/2019
- Taxonomy Code 208000000X
- Entity Type Individual
- NPI Number 1912556655
Products in Payments
- BEXSERO (Biological) $158.76
- VYVANSE (Drug) $92.87
- Azstarys (Drug) $42.84
- JORNAY PM (Drug) $41.30
- SPINRAZA (Biological) $21.95
- Crysvita (Drug) $18.70
- PEDIARIX (Biological) $15.78
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.